Ledipasvir & Sofosbuvir Tablets
Ledipasvir & Sofosbuvir Tablets Manufacturer, providing effective treatment for Hepatitis C infection with high-quality, safe, and trusted medication solutions.
Available finished formulation under our brand name Ledikast.
View Commercial Product DetailsFormulation Insights
Comprehensive Medical Overview
Ledipasvir & Sofosbuvir Tablets
Classification - Hepatitis C antiviral medicine
What are Ledipasvir and Sofosbuvir Tablets?
It is an antiviral drug composition approved to treat chronic hepatitis C. It is used against multiple hepatitis C genotypes- 1, 4, 5, 6.
It is a newer antiviral combination.
Ledipasvir and Sofosbuvir Tablet Uses
It is used to treat –
- Chronic Hepatitis C
- Failed Hepatitis C cases
- HIV co-infections
Why choose Ledikast by Aprazer Healthcare?
Ledikast, available worldwide, is the top-quality antiviral drug combination. Ledikast is the global standard hepatitis C medicine, prescribed by leading hepatologists.
Ledikast is widely used in post-liver transplant care to treat Hepatitis C infections.
Aprazer Healthcare – The Leadership in Antiviral Therapies
Aprazer Healthcare leads the way in antiviral drug manufacturing. We are the top Hepatitis C medicine manufacturers. We develop a range of Hepatitis C medicines, Hepatitis B medicines, and HIV medicines.
Manufacturing an affordable range of antivirals, we are the leading hepatitis medicine exporter. Our quality exports include –
- (Ledipasvir, Sofosbuvir) - Ledikast
- (Sofosbuvir, Velpatasvir) - Velakast
Ledipasvir, Sofosbuvir: Adverse Effects
It is the newer antiviral drug combination. It is approved to have fewer severe side effects.
The usual side effects caused are -
- Nausea
- Vomiting
- Diarrhea
- Stomach upset
- Mood upset
Severe Side-effects- Ledipasvir and Sofosbuvir
The side effects created by newer generation drugs are tolerable and less severe.
The most severe side-effect caused is Hepatitis B reactivation.
Other severe side-effects include-
- Pain in the abdomen
- Suppressed heart rate
- Liver failure
- Allergic reaction
Ledipasvir and Sofosbuvir: Working
It consists of two important drugs. It provides effective viral suppression.
Ledipasvir and Sofosbuvir inhibit DNA polymerase and stop viral cell replication.
Benefits
The combination offers a synergistic effect.
It offers potent viral suppression.
It reduces the resistance.
It has better tolerability and safety.
Precautions for Ledipasvir and Sofosbuvir
To be used cautiously in patients
- Hepatitis B infections
- HIV infections
- Heart disorders
- Liver disorders
- Pregnant and breastfeeding women
- In children
- Kidney disorders
Warning
- Allergy or hypersensitivity to drug components.
- It should not be used in End-stage renal disease
- Not to be combined with Amiodarone.
- It is a prescription drug to be taken under medical supervision only.
- Not to be combined with ribavirin in pregnancy.
Important Safety and Monitoring Information
The long–term hepatitis C therapy with Ledipasvir and Sofosbuvir requires observing signs of reactivation of other infections, like Hepatitis B.
Regular monitoring of -
- Hepatic functions
- Renal functions
- Cardiac functions
- Co-infections, and
- Neuropsychiatric adverse reactions.
- Drug interactions – Ribavirin and Amiodarone
- Not to be used alone for HCV infections.
Drug Interactions
The antiviral combination interacts with other drugs, leading to reduced effectiveness and enhanced side effects.
- Ribavirin
- Antacids
- Rifampin
- Histamine blockers
- Proton pump inhibitors
- Anticoagulant
Conclusion
Ledipasvir and Sofosbuvir have a significant effect on viral suppression. It is a combination offering strong protection.
These combinations offer a simpler regimen, better patient compliance.